The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy.
D000547:Amantadine / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002744:Chlorpheniramine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists; D004357:Drug Synergism; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D008297:Male; D009966:Orphenadrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010300:Parkinson Disease / Q000188:drug therapy; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D014282:Trihexyphenidyl / Q000494:pharmacology
D018492:Dopamine Antagonists; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010880:Piperidines; D002744:Chlorpheniramine; D014282:Trihexyphenidyl; D009966:Orphenadrine; D000547:Amantadine; D000661:Amphetamine; D004298:Dopamine